The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Higher Than Normal Plasma Interleukin-6 Concentrations in Cancer Patients With Depression: Preliminary Findings
Abstract
OBJECTIVE: This study investigated whether cancer patients with and without major depression exhibit immune system abnormalities similar to those reported in medically healthy, depressed subjects without cancer. METHOD: The study subjects consisted of patients diagnosed with pancreatic, esophageal, or breast cancer. Other groups consisted of subjects with major depression (without cancer) and healthy comparison subjects. Subjects' diagnoses were made with the Structured Clinical Interview for DSM-III-R. Severity of depression was measured with the Hamilton Depression Rating Scale. Plasma concentrations of interleukin-6 (IL-6) and postdexamethasone cortisol were measured. RESULTS: Cancer patients with depression had markedly higher plasma concentrations of IL-6 than healthy comparison subjects and cancer patients without depression. Although significant correlations were found between Hamilton depression scale scores and plasma concentrations of postdexamethasone cortisol, no significant correlations were found between plasma IL-6 and postdexamethasone cortisol concentrations. CONCLUSIONS: Higher than normal plasma IL-6 concentrations were associated with a diagnosis of major depression in cancer patients. IL-6 may contribute to sickness behavior that has overlapping symptoms with major depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Immune-neuro-endocrine interactions: facts and hypotheses.
BESEDOVSKY, H. O., & REY, A. D. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-1-64 · Cited by 1,564
Biological and clinical aspects of interleukin 6
Hirano, T., Akira, S., Taga, T., & Kishimoto, T. (1990) · Immunology Today · doi:10.1016/0167-5699(90)90173-7 · Cited by 1,066
Sickness behavior as a new target for drug development
Kent, S., Bluthé, R.-M., Kelley, K. W., & Dantzer, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90012-u · Cited by 863
A molecular basis for bidirectional communication between the immune and neuroendocrine systems.
Blalock, J. E. (1989) · Physiological Reviews · doi:10.1152/physrev.1989.69.1.1 · Cited by 841
The Dexamethasone Suppression Test for Melancholia
Carroll, B. J. (1982) · British Journal of Psychiatry · doi:10.1192/bjp.140.3.292 · Cited by 769
Cited by
A Meta-Analysis of Cytokines in Major Depression
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citationAssociations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis.
Howren, M. B., Lamkin, D. M., & Suls, J. (2009) · Psychosomatic Medicine · doi:10.1097/psy.0b013e3181907c1b · Cited by 2,766
Obesity and inflammation: the linking mechanism and the complications
Ellulu, M. S., Patimah, I., Khaza’ai, H., Rahmat, A., & Abed, Y. (2017) · Archives of Medical Science · doi:10.5114/aoms.2016.58928 · Cited by 1,982
Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications
Felger, J. C., & Lotrich, F. E. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.060 · Cited by 1,180
Curcumin and cancer: An “old-age” disease with an “age-old” solution
Anand, P., Sundaram, C., Jhurani, S., Kunnumakkara, A. B., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.025 · Cited by 1,132
Mood disorders in the medically ill: scientific review and recommendations
Evans, D. L., Charney, D. S., Lewis, L., Golden, R. N., Gorman, J. M., Krishnan, K. R. R., Nemeroff, C. B., Bremner, J. D., Carney, R. M., Coyne, J. C., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.001 · Cited by 1,071
Self-citationDepressive disorders and immunity: 20 years of progress and discovery
Irwin, M. R., & Miller, A. H. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.01.010 · Cited by 676
Self-citationPosttraumatic stress disorder in general intensive care unit survivors: a systematic review
Davydow, D. S., Gifford, J. M., Desai, S. V., Needham, D. M., & Bienvenu, O. J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.05.006 · Cited by 676
Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment
Musselman, D. L., Betan, E., Larsen, H., & Phillips, L. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00569-9 · Cited by 671
Self-citationThe immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression
Müller, N., & Schwarz, M. J. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002006 · Cited by 670
Cytokines and their relationship to the symptoms and outcome of cancer
Seruga, B., Zhang, H., Bernstein, L. J., & Tannock, I. F. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2507 · Cited by 652
Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With Cancer
Miller, A. H., Ancoli-Israel, S., Bower, J. E., Capuron, L., & Irwin, M. R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.7805 · Cited by 608
Self-citationMajor depression after breast cancer: a review of epidemiology and treatment
Fann, J. R., Thomas-Rich, A. M., Katon, W. J., Cowley, D., Pepping, M., McGregor, B. A., & Gralow, J. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.10.008 · Cited by 586
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Self-citationPenninx, B. W. J. H., Kritchevsky, S. B., Yaffe, K., Newman, A. B., Simonsick, E. M., Rubin, S., Ferrucci, L., Harris, T., & Pahor, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01811-5 · Cited by 530
Depression and cardiovascular disease: mechanisms of interaction
Joynt, K. E., Whellan, D. J., & O'Connor, C. M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00568-7 · Cited by 507
Behavioral Symptoms in Patients With Breast Cancer and Survivors
Bower, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3248 · Cited by 483
Depression in cancer patients: Pathogenesis, implications and treatment (Review)
SMITH, H. R. (2015) · Oncology Letters · doi:10.3892/ol.2015.2944 · Cited by 478
Cytokines as mediators of depression: what can we learn from animal studies?
Dunn, A. J., Swiergiel, A. H., & Beaurepaire, R. D. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.023 · Cited by 459
Heartache and heartbreak—the link between depression and cardiovascular disease
Nemeroff, C. B., & Goldschmidt-Clermont, P. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.91 · Cited by 424
Self-citationInflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors
Collado-Hidalgo, A., Bower, J. E., Ganz, P. A., Cole, S. W., & Irwin, M. R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2398 · Cited by 394
Kiecolt-Glaser, J. K., Bennett, J. M., Andridge, R., Peng, J., Shapiro, C. L., Malarkey, W. B., Emery, C. F., Layman, R., Mrozek, E. E., & Glaser, R. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.8860 · Cited by 389
Role of Interleukin-6 in Depressive Disorder
Ting, E. Y.-C., Yang, A. C., & Tsai, S.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062194 · Cited by 385
Th1, Th2, and Th3 cytokine alterations in major depression
MYINT, A., LEONARD, B., STEINBUSCH, H., & KIM, Y. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.07.008 · Cited by 371
Neurobiology of depression, fibromyalgia and neuropathic pain
Maletic, V. (2009) · Frontiers in Bioscience · doi:10.2741/3598 · Cited by 366
Mixed anxiety/depression symptoms in a large cancer cohort: prevalence by cancer type
Brintzenhofe-Szoc, K. M., Levin, T. T., Li, Y., Kissane, D. W., & Zabora, J. R. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.4.383 · Cited by 364
The role of intratumoral and systemic IL-6 in breast cancer
Dethlefsen, C., Højfeldt, G., & Hojman, P. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2488-z · Cited by 363
Depression in cancer: new developments regarding diagnosis and treatment
Raison, C. L., & Miller, A. H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00413-x · Cited by 336
Self-citationPsychiatric Morbidity in Survivors of the Acute Respiratory Distress Syndrome: A Systematic Review
Davydow, D. S., Desai, S. V., Needham, D. M., & Bienvenu, O. J. (2008) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31816aa0dd · Cited by 331
An fMRI study of cytokine-induced depressed mood and social pain: The role of sex differences
Eisenberger, N. I., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.04.040 · Cited by 313
Decramer, M., Rennard, S., Troosters, T., Mapel, D. W., Giardino, N., Mannino, D., Wouters, E., Sethi, S., & Cooper, C. B. (2008) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550802237531 · Cited by 295
Kunz-Ebrecht, S. R., Mohamed-Ali, V., Feldman, P. J., Kirschbaum, C., & Steptoe, A. (2003) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(03)00029-1 · Cited by 288
Acute inflammation and negative mood: mediation by cytokine activation
Wright, C. E., Strike, P. C., Brydon, L., & Steptoe, A. (2005) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.10.003 · Cited by 287
“Cancer patients with depression have higher plasma concentrations of IL-6 than healthy controls or cancer patients without depression (Musselman et al., 2001a), and depressive symptoms are common in conditions associated with cytokine activation, including autoimmune diseases, stroke, trauma and…”
BackgroundShelton, R. C., & Miller, A. H. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.004 · Cited by 261
Self-citationRich, T., Innominato, P. F., Boerner, J., Mormont, M. C., Iacobelli, S., Baron, B., Jasmin, C., & Lévi, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2000 · Cited by 259
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors
Chourbaji, S., Urani, A., Inta, I., Sanchis-Segura, C., Brandwein, C., Zink, M., Schwaninger, M., & Gass, P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.05.001 · Cited by 241
Inflammation-Associated Co-morbidity Between Depression and Cardiovascular Disease
Halaris, A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_28 · Cited by 233
Systematic review of the association between circulating interleukin-6 (IL-6) and cancer
Heikkilä, K., Ebrahim, S., & Lawlor, D. A. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.02.047 · Cited by 232
Pitharouli, M. C., Hagenaars, S. P., Glanville, K. P., Coleman, J. R. I., Hotopf, M., Lewis, C. M., & Pariante, C. M. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20060947 · Cited by 218
Depression and sterile inflammation: essential role of danger associated molecular patterns
Franklin, T. C., Xu, C., & Duman, R. S. (2018) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2017.10.025 · Cited by 204
Tu, B., Du, L., Fan, Q.-M., Tang, Z., & Tang, T.-T. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.06.006 · Cited by 196
Depression in patients with rheumatoid arthritis: description, causes and mechanisms
Margaretten, M., Julian, L., Katz, P., & Yelin, E. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.11.62 · Cited by 183
Inflammatory cytokine-associated depression
Lotrich, F. E. (2015) · Brain Research · doi:10.1016/j.brainres.2014.06.032 · Cited by 183
Depression, comorbidities and the TNF-α system
Himmerich, H., Fulda, S., Linseisen, J., Seiler, H., Wolfram, G., Himmerich, S., Gedrich, K., Kloiber, S., Lucae, S., Ising, M., et al. (2008) · European Psychiatry · doi:10.1016/j.eurpsy.2008.03.013 · Cited by 181
Sleep disturbance, inflammation and depression risk in cancer survivors
Irwin, M. R., Olmstead, R. E., Ganz, P. A., & Haque, R. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2012.05.002 · Cited by 173
Depressive symptoms enhance stress-induced inflammatory responses.
Fagundes, C. P., Glaser, R., Hwang, B. S., Malarkey, W. B., & Kiecolt-Glaser, J. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.05.006 · Cited by 151
“The association between inflammation and depressive symptoms has been found in a variety of different populations (Alesci et al., 2005; Bouhuys et al., 2004; Miller et al., 2002; Musselman et al., 2001).”
BackgroundThe role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder
Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150
Patten, S. B., Kennedy, S. H., Lam, R. W., O'Donovan, C., Filteau, M. J., Parikh, S. V., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.044 · Cited by 148
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Biomarkers of depression in cancer patients
Jehn, C. F., Kuehnhardt, D., Bartholomae, A., Pfeiffer, S., Krebs, M., Regierer, A. C., Schmid, P., Possinger, K., & Flath, B. C. (2006) · Cancer · doi:10.1002/cncr.22294 · Cited by 139
Cytokine-induced depression during IFN-α treatment: The role of IL-6 and sleep quality
Prather, A. A., Rabinovitz, M., Pollock, B. G., & Lotrich, F. E. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.07.001 · Cited by 139
Depression as a Risk Factor for Cancer: From Pathophysiological Advances to Treatment Implications
Currier, M. B., & Nemeroff, C. B. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-061212-171507 · Cited by 126
Self-citationSteel, J. L., Geller, D. A., Kim, K. H., Butterfield, L. H., Spring, M., Grady, J., Sun, W., Marsh, W., Antoni, M., Dew, M. A., et al. (2016) · Cancer · doi:10.1002/cncr.29906 · Cited by 116
Depression, cytokines, and pancreatic cancer
Breitbart, W., Rosenfeld, B., Tobias, K., Pessin, H., Ku, G. Y., Yuan, J., & Wolchok, J. (2014) · Psycho-Oncology · doi:10.1002/pon.3422 · Cited by 106
Irwin, M., Rinetti, G., Redwine, L., Motivala, S., Dang, J., & Ehlers, C. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2004.02.001 · Cited by 95
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
Barrera, I., & Spiegel, D. (2014) · International Review of Psychiatry · doi:10.3109/09540261.2013.864259 · Cited by 75
Depression subtypes in pediatric inflammatory bowel disease
Szigethy, E. M., Youk, A. O., Benhayon, D., Fairclough, D. L., Newara, M. C., Kirshner, M. A., Bujoreanu, S. I., Mrakotsky, C., Bousvaros, A., Srinath, A. I., et al. (2014) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000262 · Cited by 65
The Phosphodiesterase Type 4 Inhibitor, Rolipram, Enhances Glucocorticoid Receptor Function
Miller, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00381-0 · Cited by 57
Self-citationMarinac, C. R., Nelson, S. H., Flatt, S. W., Natarajan, L., Pierce, J. P., & Patterson, R. E. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4140-9 · Cited by 55
Dooley, L. N., Ganz, P. A., Cole, S. W., Crespi, C. M., & Bower, J. E. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.059 · Cited by 50
Role of natural products in breast cancer related symptomology: Targeting chronic inflammation
Andrijauskaite, K., & Wargovich, M. J. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.011 · Cited by 38
Gaarden, T. L., Engedal, K., Benth, J. Š., Larsen, M., Lorentzen, B., Mollnes, T. E., Bjølseth, T. M., & Castellheim, A. (2018) · BMC Geriatrics · doi:10.1186/s12877-018-0836-x · Cited by 32
Cancer-related fatigue: impact on patient quality of life and management approaches
Yeo, T. P., & Cannaday, S. (2015) · Nursing: Research and Reviews · doi:10.2147/nrr.s41957 · Cited by 21
Ushiroyama, T., Ikeda, A., & Ueki, M. (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(02)00189-3 · Cited by 20
Circulating Cytokines as Predictors of Depression in Patients with Breast Cancer
Ho, H.-Y., Chin-Hung Chen, V., Tzang, B.-S., Hsieh, C.-C., Wang, W.-K., Weng, Y.-P., Hsu, Y.-T., Hsaio, H.-P., Weng, J.-C., & Chen, Y.-L. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.02.037 · Cited by 20
Metadata
- Authors
- Musselman, D. L., Miller, A. H., Porter, M. R., Manatunga, A., Gao, F., Penna, S., Pearce, B. D., Landry, J., Glover, S., McDaniel, J. S., & Nemeroff, C. B.
- Venue
- American Journal of Psychiatry
- Published
- 2001-08-01
- Volume
- 158
- Issue
- 8
- Pages
- 1252-1257
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2008489516
- Cited by
- 445
- References
- 41
- FWCI
- 4.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.